New research has found that 50% of patients regain the weight they lost if they stop taking Wegovy and Zepbound ...

MEDVi, a telehealth platform serving more than 100,000 patients, today announced an expanded physician-led program ...

Consumers say that smaller doses of a popular weight-loss drug eased side effects and improved their health Telehealth ...

The request comes after a two-year review into reported links between GLP-1RAs and psychiatric adverse events.

Friendly” labels on the packaging are becoming more common in U.S. supermarkets as a growing number of Americans try obesity ...

Many people who stop using weight loss drugs will return to their previous weight within two years, a new review of existing ...

Federal health regulators say popular weight loss drugs like Wegovy and Zepbound do not increase the risk of suicidal thoughts, and they have asked drugmakers to remove those warnings from medication ...

The discussion surrounding GLP-1 medications needs to change to one that emphasizes science-based research and compassion.

So I wasn’t surprised when Williams was hit with a whole lot of “how dare you”—as Oprah Winfrey put it on the January 13 ...

Research has shown that people who stop taking GLP-1 drugs, such as Ozempic and Wegovy, typically experience weight regain ...

The FDA is requesting that manufacturers of three GLP-1 receptor agonists remove information on risk for suicidal ideation ...

Since we know that eating less food often means getting fewer nutrients, a high-quality multivitamin acts as an insurance ...